Ark Genomic Revolution Etf Ten Year Return
| ARKG Etf | USD 25.04 0.85 3.51% |
ARK Genomic Revolution fundamentals help investors to digest information that contributes to ARK Genomic's financial success or failures. It also enables traders to predict the movement of ARK Etf. The fundamental analysis module provides a way to measure ARK Genomic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ARK Genomic etf.
ARK |
ARK Genomic Revolution ETF Ten Year Return Analysis
ARK Genomic's Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
| Competition |
Based on the latest financial disclosure, ARK Genomic Revolution has a Ten Year Return of 0.0%. This indicator is about the same for the ARK ETF Trust average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. The ten year return for all United States etfs is 100.0% higher than that of the company.
ARK Ten Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ARK Genomic's direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of ARK Genomic could also be used in its relative valuation, which is a method of valuing ARK Genomic by comparing valuation metrics of similar companies.ARK Genomic is currently under evaluation in ten year return as compared to similar ETFs.
Fund Asset Allocation for ARK Genomic
The fund invests 99.63% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides ARK Genomic's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
ARK Fundamentals
| Price To Earning | 41.86 X | |||
| Price To Book | 3.26 X | |||
| Price To Sales | 7.63 X | |||
| Number Of Employees | 330 | |||
| Beta | 1.77 | |||
| Total Asset | 2.36 B | |||
| One Year Return | (13.20) % | |||
| Three Year Return | (33.70) % | |||
| Five Year Return | (4.70) % | |||
| Net Asset | 2.36 B | |||
| Last Dividend Paid | 1.05 | |||
| Equity Positions Weight | 99.63 % |
About ARK Genomic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ARK Genomic Revolution's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ARK Genomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ARK Genomic Revolution based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ARK Genomic Implied Volatility | 46.78 |
ARK Genomic's implied volatility exposes the market's sentiment of ARK Genomic Revolution stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ARK Genomic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ARK Genomic stock will not fluctuate a lot when ARK Genomic's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ARK Genomic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ARK Genomic's short interest history, or implied volatility extrapolated from ARK Genomic options trading.
Pair Trading with ARK Genomic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ARK Genomic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARK Genomic will appreciate offsetting losses from the drop in the long position's value.Moving together with ARK Etf
| 0.78 | XLV | Health Care Select | PairCorr |
| 0.79 | VHT | Vanguard Health Care | PairCorr |
| 0.91 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.83 | XBI | SPDR SP Biotech Aggressive Push | PairCorr |
| 0.74 | IHI | iShares Medical Devices | PairCorr |
Moving against ARK Etf
| 0.89 | TSJA | TSJA | PairCorr |
| 0.71 | DSJA | DSJA | PairCorr |
The ability to find closely correlated positions to ARK Genomic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ARK Genomic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ARK Genomic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ARK Genomic Revolution to buy it.
The correlation of ARK Genomic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ARK Genomic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ARK Genomic Revolution moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ARK Genomic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ARK Genomic Piotroski F Score and ARK Genomic Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.